Universitätsmedizin Göttingen

Futó vizsgálatok

• Még nem toboroz

  Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

  NCT07291102· 3. fázis· Nationwide Children's Hospital· Forrás

• Még nem toboroz

  A clinical trial to learn more about the effects of AAA817 given with an androgen receptor pathway inhibitor (ARPI) in men with prostate cancer

  2024-512340-32-01· 3. fázis· Novartis Pharma AG· Forrás

• Még nem toboroz

  Post-intervention dual antiplatelet therapy for mild stroke

  2026-525681-22-00· 3. fázis· Technische Universitaet Dresden· Forrás

• Még nem toboroz

  Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients - NB2015-LR

  2024-517295-37-00· 3. fázis· University Of Cologne· Forrás

• Még nem toboroz

  Safety and Efficacy Comparison Between CHF5993 100/6 12.5µg pMDI to Seretide Evohaler 125/25µg pMDI in Adolescent Subjects With Asthma

  NCT07858123· 3. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Még nem toboroz

  A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis

  NCT07873801· 3. fázis· Almirall, S.A.· Forrás

• Toboroz

  A Study to evaluate effect of AZD6234 in adult participants with Type 2 Diabetes Mellitus and obesity or overweight

  2025-524616-11-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07465289· 3. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)

  2025-525009-18-00· 3. fázis· Incyte Corp.· Forrás

• Toboroz

  Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

  NCT07473128· 3. fázis· Pharmacosmos A/S· Forrás

• Még nem toboroz

  AIEOP-BFM ALL 2025 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia

  2025-522190-11-01· 3. fázis· Universitaetsklinikum Schleswig-Holstein AöR· Forrás

• Még nem toboroz

  Phase 2 Trial of TAK-755 for Acute Ischemic Stroke

  2025-522734-31-00· 2. fázis· Takeda Development Center Americas Inc.· Forrás

• Toboroz

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  NCT07753993· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A study to find out if enfortumab vedotin given with pembrolizumab helps people with muscle-invasive bladder cancer keep their bladder.

  2025-524488-18-00· 2. fázis· Astellas Pharma Global Development Inc.· Forrás

• Toboroz

  A double-dummy, double-blind, randomized, active controlled, two-way cross-over study with 12-week treatment duration per period, to evaluate the efficacy and safety of QVM149 (indacaterol acetate / glycopyrronium bromide / mometasone furoate) compared to salmeterol xinafoate/fluticasone propionate in children from 12 years to less than 18 years of age with asthma.

  2022-502365-26-00· 3. fázis· Novartis Pharma AG· Forrás

• Toboroz

  A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  NCT07784725· 3. fázis· AstraZeneca· Forrás

• Toboroz

  A study to evaluate the efficacy of oxaliplatin- or gemcitabine-based chemotherapy after allocation by standard criteria or by genetic markers in patients with resected pancreatic carcinoma

  NCT05314998· 3. fázis· Universitaetsklinikum Heidelberg AöR· Forrás

• Még nem toboroz

  Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.

  2026-525883-17-00· 3. fázis· Genmab A/S· Forrás

• Toboroz

  A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

  NCT07711418· 3. fázis· Nektar Therapeutics· Forrás

• Toboroz

  The RAPID-Elapse study: Can the drug bupropion improve fatigue symptoms in patients with long COVID?

  2025-524443-12-00· 2. fázis· Goethe University Frankfurt· Forrás

• Toboroz

  Registry for Duchenne and Becker Muscular Dystrophy

  NCT07402122· Dr. Andreas Ziegler· Forrás

• Toboroz

  ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis

  NCT07673627· 2. fázis· argenx· Forrás

• Még nem toboroz

  Does a higher radiation dose prolong survival of patients with limited-stage small cell lung cancer receiving immunotherapy after chemotherapy and radiation therapy (DAHRTS trial)?

  2026-525513-31-00· 3. fázis· Norges Teknisk-Naturvitenskapelige Universitet NTNU· Forrás

• Még nem toboroz

  GMMG-HD11/DSMM XXI/64007957MMY3010

  NCT07671287· 3. fázis· University of Heidelberg Medical Center· Forrás

• Toboroz

  A clinical trial to provide continued access to remibrutinib (LOU064) for people who are benefiting from it in a previous remibrutinib trial

  2025-524078-40-00· 3. fázis· Novartis Pharma AG· Forrás

• Toboroz

  Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial.

  NCT07333066· 3. fázis· Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07463521· 3. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  A Study of TAK-755 in Adults With Acute Ischemic Stroke

  NCT07392450· 2. fázis· Takeda· Forrás

• Toboroz

  Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

  NCT07486934· 3. fázis· Dyne Therapeutics· Forrás

• Toboroz

  Pembro-FLASH

  NCT06045159· 2. fázis· University Of Cologne· Forrás

• Toboroz

  DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

  NCT07472517· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Improved Management of Patients With Recent-Onset Stable Chest Pain

  NCT07476040· Philipps University Marburg· Forrás

• Toboroz

  A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

  NCT07361497· 3. fázis· Bristol-Myers Squibb· Forrás

• Fut, nem toboroz

  A study to learn about how well BAY 3401016 works in adults with Alport syndrome

  2024-516471-33-00· 2. fázis· Bayer AG· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  NCT07221357· 2/3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

  NCT07294170· argenx· Forrás

• Toboroz

  ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

  NCT07284420· 2. fázis· argenx· Forrás

• Toboroz

  Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma

  2022-500676-59-00· 2. fázis· GPOH gGmbH· Forrás

• Toboroz

  Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment

  NCT07314164· Ipsen· Forrás

• Toboroz

  STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease

  NCT07280585· 3. fázis· University of Cologne· Forrás

• Toboroz

  SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension

  NCT06804161· 3. fázis· Prof. Dr. med. Ingo Eitel· Forrás

• Toboroz

  Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure

  NCT07038356· 3. fázis· Christian Schulze· Forrás

• Toboroz

  A randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy

  2024-515125-28-00· 2. fázis· Imbria Pharmaceuticals Inc.· Forrás

• Még nem toboroz

  A Phase 2 Trial Evaluating the Effects of Thiethylperazine as diagnostic tool and therapeutic agent in Patients Diagnosed with an Early Stage of Alzheimer's disease

  2022-501137-23-00· 2. fázis· Immungenetics AG· Forrás

• Toboroz

  Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.

  2024-516906-47-00· 2/3. fázis· Daiichi Sankyo Inc.· Forrás

• Toboroz

  A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD

  NCT06847542· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

  NCT07227402· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

  NCT07160608· 2. fázis· Alexion Pharmaceuticals, Inc.· Forrás

• Toboroz

  PIRTOBRUTINIB AND GLOFITAMAB IN MANTLE CELL LYMPHOMA

  2024-512922-27-00· 2. fázis· Klinikum der Universitaet Muenchen AöR· Forrás

• Toboroz

  Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma

  NCT07260175· 2. fázis· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Forrás

Showing 50 of 230.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Gyermekkori daganatok19 toboroz
• Tüdőrák12 toboroz
• Szívelégtelenség10 toboroz
• Stroke (szélütés)8 toboroz
• Myasthenia gravis7 toboroz
• Szarkóma6 toboroz
• Vastagbélrák6 toboroz
• Akut limfoid leukémia (ALL)5 toboroz
• Alzheimer-kór5 toboroz
• Időskori makuladegeneráció5 toboroz
• Máj- és epeúti rák5 toboroz
• Dermatomyositis and polymyositis (myositis)4 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)4 toboroz
• Koszorúér-betegség4 toboroz
• Prosztatarák4 toboroz
• Antiphospholipid syndrome3 toboroz
• Atópiás dermatitisz (ekcéma)3 toboroz
• Elhízás3 toboroz
• Follikuláris limfóma3 toboroz
• Hasnyálmirigyrák3 toboroz
• Immune thrombocytopenia (ITP)3 toboroz
• Krónikus vesebetegség3 toboroz
• Myotonic dystrophy3 toboroz
• 2-es típusú cukorbetegség2 toboroz
• Asztma2 toboroz
• Duchenne-izomdisztrófia2 toboroz
• Fej-nyaki daganatok2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• Hearing loss2 toboroz
• Hipertrófiás kardiomiopátia2 toboroz
• Hólyagrák2 toboroz
• Köpenysejtes limfóma2 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)2 toboroz
• Magas vérnyomás2 toboroz
• Melanóma2 toboroz
• Mielodiszplasztikus szindróma (MDS)2 toboroz
• Parkinson-kór2 toboroz
• Pitvarfibrilláció2 toboroz
• Retinitis pigmentosa2 toboroz
• 1-es típusú cukorbetegség1 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Amiloidózis1 toboroz
• Aortic aneurysm1 toboroz
• Áttétes emlőrák1 toboroz
• Brain aneurysm1 toboroz
• Chronic spontaneous urticaria1 toboroz
• Hidradenitis suppurativa1 toboroz
• HIV-fertőzés1 toboroz
• Hodgkin-limfóma1 toboroz
• Huntington-kór1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Long COVID és ME/CFS1 toboroz
• Lupus (SLE)1 toboroz
• Méhnyakrák1 toboroz
• Mezotelióma1 toboroz
• Mielóma multiplex1 toboroz
• Mild cognitive impairment1 toboroz
• Multiple system atrophy1 toboroz
• Myocarditis1 toboroz
• Neuroblasztóma1 toboroz
• Neuroendokrin daganatok1 toboroz
• Petefészekrák1 toboroz
• Policisztás vesebetegség1 toboroz
• Skizofrénia1 toboroz
• Vascular dementia1 toboroz
• Vesedaganat1 toboroz
• Vitiligo1 toboroz

Lezárt vizsgálatok

• Visszavonták

  Confirmatory Study of Govorestat in CMT-SORD

  NCT07191912· 3. fázis· Applied Therapeutics, Inc.· Forrás

• Lezárult

  Improving Dental Care for Patients With Head and Neck Tumors

  NCT07328347· University Medical Center Goettingen· Forrás

• Lezárult

  A Study Evaluating BFB759 in Atopic Dermatitis

  2025-521624-30-00· 2. fázis· Bluefin Biomedicine Inc.· Forrás

• Lezárult

  Facilitators and Barriers to Dental Care in Head and Neck Cancer Patients

  NCT06559384· University Medical Center Goettingen· Forrás

• Lezárult

  CABONEN – a phase II trial of Cabozantinib in patients with advanced, low proliferative NEN G3

  NCT04524208· 2. fázis· Universitaetsmedizin Goettingen· Forrás

• Lezárult

  Cognitive Function, Depression, Anxiety, and Quality of Life in Chronic Heart Failure Patients with Iron Deficiency with and without Anaemia: Effects of Intravenous Iron (Ferric Derisomaltose) CogFer-HF Study

  2024-515046-17-00· 4. fázis· Universitaetsmedizin Goettingen· Forrás

• Lezárult

  Study to assess the safety, pharmacokinetics and efficacy of HMPL-523 in patients with Immune Thrombocytopenia

  2023-508819-23-00· 1. fázis· Hutchmed Ltd.· Forrás

• Lezárult

  Randomized adaptive assessment of post COVID syndrome treatments (RAPID) Reducing Inflammatory Activity in Patients with post COVID Syndrome (REVIVE)

  2024-511628-16-00· 2. fázis· Goethe University Frankfurt· Forrás

• Lezárult

  SpinChip Hs-cTnI Clinical Diagnostic Performance

  NCT06499519· SpinChip Diagnostics ASA· Forrás

• Lezárult

  A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.

  NCT06431763· 4. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

  NCT06384547· 3. fázis· Viridian Therapeutics, Inc.· Forrás

• Fut, nem toboroz

  A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

  NCT06346067· 3. fázis· Erasca, Inc.· Forrás

• Fut, nem toboroz

  Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma

  NCT06216158· 3. fázis· University of Heidelberg Medical Center· Forrás

• Visszavonták

  A Study of Macitentan in Children Below 2 Years of Age

  NCT05731492· 1. fázis· Actelion· Forrás

• Lezárult

  Efficacy of MindAhead's Digital Behavioral Activation Therapy in Adults with MCI or Mild Dementia

  NCT06149013· MindAhead UG· Forrás

• Lezárult

  Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)

  NCT06122961· Novo Nordisk A/S· Forrás

• Lezárult

  Mavacamten Impact on Myocardial Structure in Obstructive Hypertrophic Cardiomyopathy

  2022-502316-36-00· 4. fázis· Myokardia Inc.· Forrás

• Lezárult

  An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

  NCT06021054· 3. fázis· Viridian Therapeutics, Inc.· Forrás

• Leállították

  Prospective Study to Evaluate Patient Reported Outcomes (PRO) During Rechallenge With Trabectedin in Sarcoma Patients

  NCT06050434· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Forrás

• Lezárult

  A Phase 3b, Open-label Study to Evaluate the Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

  2023-505558-16-00· 3. fázis· Almirall S.A.· Forrás

• Lezárult

  Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

  NCT05882734· 1/2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Fut, nem toboroz

  A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

  NCT06081894· 3. fázis· Cytokinetics· Forrás

• Lezárult

  A Phase 2 Study of the Effects of Ponsegromab on Health-Related Quality of Life and Safety in Patients With Heart Failure (GARDEN-TIMI 74)

  NCT05492500· 2. fázis· Pfizer Inc.· Forrás

• Lezárult

  Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

  NCT05819398· 2/3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Cardiomyopathy

  NCT05582395· 3. fázis· Myokardia Inc.· Forrás

• Leállították

  Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy

  NCT05570409· 2/3. fázis· LMU Klinikum· Forrás

• Lezárult

  Vamikibart in Participants With Uveitic Macular Edema

  NCT05642325· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

  NCT05499832· 3. fázis· Insel Gruppe AG, University Hospital Bern· Forrás

• Lezárult

  Glucocorticoid enhancement of food exposure therapy in Binge Eating Disorder

  2024-515475-35-00· 2. fázis· Universitaetsmedizin Goettingen· Forrás

• Lezárult

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Allogeneic stem cell transplantation vs. conventional therapy as salvage therapy for relapsed / progressed patients with multiple myeloma after first-line therapy (AlloRelapseMMStudy)

  NCT05675319· 3. fázis· University Medical Center Hamburg-Eppendorf· Forrás

• Lezárult

  A multicenter, randomized, double-blind, placebo-controlled TRial evaluating Immunosuppressive treatment in patients with chronic virus-Negative Inflammatory cardiomyopaThY (TRINITY trial)

  2024-512451-20-00· 2/3. fázis· Klinikum der Universitaet Muenchen AöR· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)

  NCT05620836· 3. fázis· Incyte Corporation· Forrás

• Lezárult

  A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05724199· 3. fázis· Amgen· Forrás

• Fut, nem toboroz

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· 3. fázis· Bayer· Forrás

• Leállították

  Prednisolone Versus Colchicine for Acute Gout in Primary Care

  NCT05698680· 4. fázis· University Medicine Greifswald· Forrás

• Lezárult

  Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN High Risk, Cisplatin-ineligible Participants (XRAY VISION)

  2023-508528-36-00· 3. fázis· Merck Healthcare KGaA· Forrás

• Lezárult

  A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)

  NCT05176639· 3. fázis· Viridian Therapeutics, Inc.· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

  NCT05523167· 2/3. fázis· argenx· Forrás

• Leállították

  A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

  NCT05310071· 3. fázis· Biogen· Forrás

• Lezárult

  Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

  NCT05239169· 2. fázis· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Forrás

• Lezárult

  Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy

  NCT05101629· 2. fázis· Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest· Forrás

• Lezárult

  Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation

  NCT05198934· 3. fázis· Amgen· Forrás

• Lezárult

  Study to understand if inclisiran is better than a placebo at lowering LDL-cholesterol,is safe and can have an impact on patient quality of life, when given along with other lipid lowering medications.

  2024-511263-28-00· 4. fázis· Novartis Pharma AG· Forrás

• Lezárult

  Effect of antifibrotic therapy on regression of myocardial fibrosis after transcatheter aortic valve implantation (TAVI) in aortic stenosis patients with high fibrotic burden

  2024-510869-42-00· 2. fázis· Universitaetsmedizin Goettingen· Forrás

• Lezárult

  A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling

  NCT04773782· 1/2. fázis· Blueprint Medicines Corporation· Forrás

• Lezárult

  Tiotropium in preventing preschool asthma (TIPP)

  2024-513916-84-00· 3. fázis· Goethe University Frankfurt· Forrás

• Fut, nem toboroz

  D,L-MEthadone and mFOLFOX6 in Treatment of Advanced Colorectal Cancer

  NCT05212012· 1/2. fázis· AIO-Studien-gGmbH· Forrás

• Lezárult

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM

  NCT05186818· 3. fázis· Cytokinetics· Forrás

Showing 50 of 93.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Alzheimer-kór113 munka · 9 vizsgálat
• Parkinson-kór71 munka · 2 vizsgálat
• Pitvarfibrilláció49 munka · 3 vizsgálat
• Sclerosis multiplex (SM)31 munka · 2 vizsgálat
• Mild cognitive impairment27 munka · 4 vizsgálat
• Myasthenia gravis14 munka · 9 vizsgálat
• Lewy-testes demencia13 munka · 0 vizsgálat
• Dilated cardiomyopathy13 munka · 1 vizsgálat
• Aortic stenosis12 munka · 4 vizsgálat
• Amiotrófiás laterálszklerózis (ALS)12 munka · 0 vizsgálat
• Long COVID és ME/CFS10 munka · 2 vizsgálat
• Neuromyelitis optica (NMOSD)9 munka · 0 vizsgálat
• Frontotemporális demencia8 munka · 0 vizsgálat
• Hydrocephalus7 munka · 0 vizsgálat
• Brain aneurysm6 munka · 1 vizsgálat
• Thymoma and thymic carcinoma6 munka · 0 vizsgálat
• Retinitis pigmentosa5 munka · 2 vizsgálat
• Multiple system atrophy5 munka · 1 vizsgálat
• Mitochondrial disease3 munka · 0 vizsgálat
• Lichen planus3 munka · 0 vizsgálat